Melanoma in situ of the left upper eyelid, including the canthus, is a localized skin cancer characterized by the uncontrolled growth of melanocytes. This condition is clinically significant as it can progress to invasive melanoma if left untreated. Accurate coding with ICD-10 Code D03.121 facilitates precise diagnosis, documentation, medical billing, and public health reporting, ensuring appropriate patient management and resource allocation.
ICD-10 Code D03.121 specifically denotes melanoma in situ located on the left upper eyelid, including the canthus. This code is utilized when documenting cases of melanoma that have not invaded deeper tissues. It is essential for accurate clinical documentation and billing, particularly in dermatology and oncology settings, to ensure proper treatment and follow-up care.
Melanoma in situ of the left upper eyelid, including canthus, arises from the malignant transformation of melanocytes, often due to UV exposure or genetic predisposition. It is crucial to identify and treat this condition promptly to prevent progression to invasive melanoma.
ICD-10 Code D03.121 is integral in SOAP notes for documenting the patient's symptoms, assessment findings, and treatment plans. It is relevant in both acute and chronic care settings, ensuring comprehensive patient management and accurate billing.
In SOAP notes, ICD-10 Code D03.121 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of melanoma in situ. This code supports continuity of care, facilitates billing, and meets EHR documentation standards.
Prompt treatment of melanoma in situ is essential to prevent progression. Surgical excision is the primary treatment modality.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D03.121 is critical for accurate billing in hospital, ER, or outpatient settings.
| CPT Code | Description |
|---|---|
| 11400 | Excision, benign skin lesion, face, ears, scalp, neck; excised diameter up to 1.0 cm. |
| 11401 | Excision, benign skin lesion, face, ears, scalp, neck; excised diameter over 1.0 cm. |
| 99213 | Established patient office visit, level 3. |
| 99214 | Established patient office visit, level 4. |
Common Questions About Using ICD-10 Code D03.121 for Melanoma in situ of left upper eyelid, including canthus
What are the risk factors for melanoma in situ?
Risk factors include excessive UV exposure, fair skin, a history of skin cancer, and the presence of atypical moles. Regular skin checks are essential for early detection.
How is melanoma in situ treated?
Melanoma in situ is primarily treated through surgical excision. Mohs micrographic surgery may be considered for lesions in cosmetically sensitive areas.
Is melanoma in situ contagious?
No, melanoma in situ is not contagious. It is a localized skin cancer that arises from genetic and environmental factors.
How often should follow-up appointments occur after treatment?
Follow-up appointments should typically occur every 3 to 6 months for the first few years after treatment, depending on the individual risk factors and physician recommendations.
Clinical Notes
SOAP notes
DAP notes
AI medical notes